Philip A. Sharp, Director at BIOGEN IDEC INC. (BIIB), sold 7,500 shares at $64.82 ($486K) on 2008-04-08, disclosed to the SEC on 2008-04-10.
Scheduled sale ($486k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.81 | 200 | $13K | 2.7% |
| 2 | $64.82 | 1,200 | $78K | 16.0% |
| 3 | $64.83 | 1,000 | $65K | 13.3% |
| 4 | $64.84 | 600 | $39K | 8.0% |
| 5 | $64.85 | 400 | $26K | 5.3% |
| 6 | $64.86 | 903 |
| $59K |
| 12.0% |
| 7 | $64.87 | 397 | $26K | 5.3% |
| 8 | $64.88 | 1,100 | $71K | 14.7% |
| 9 | $64.89 | 300 | $19K | 4.0% |
| 10 | $64.90 | 600 | $39K | 8.0% |
| 11 | $64.94 | 700 | $45K | 9.3% |
| 12 | $64.95 | 100 | $6K | 1.3% |
| Total | $64.86 avg | 7,500 | $486K | 100% |
| Filing → |
| ALNY | SELL | 2018-03-13 | $1.9M | — | Filing → |
| ALNY | SELL | 2017-02-03 | $2.0M | — | Filing → |
| ALNY | SELL | 2017-01-27 | $569K | — | Filing → |